Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Kerman

Showing results (101-110 of 135) with videos related to

Pageof 14
Sort By:
Transplantation Proceedings|April 1, 1986
Long-term results of cyclosporine therapy in recipients of mismatched living related kidneysS M Flechner, C T Van Buren, R H Kerman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1997
Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosisS A Brod, R H Kerman, L D Nelson, et al.
Transplantation|February 1, 1991
Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapyR J Knight, R H Kerman, M Welsh, et al.
Transplantation|January 1, 1988
The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppressionP C Johnson, R M Lewis, D L Golden, et al.
Transplantation|February 1, 1989
Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy--five year follow-upR M Lewis, R P Janney, D L Golden, et al.
Transplantation Proceedings|April 26, 2005
Transplantation of single pediatric kidneys into adult recipientsZ Csapo, R J Knight, H Podder, et al.
Transplantation|February 1, 1991
Preemptive transplantation--an analysis of benefits and hazards in 85 casesS M Katz, R H Kerman, D Golden, et al.
Transplantation|February 1, 1991
AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survivalR H Kerman, P M Kimball, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1991
Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipientsR H Kerman, P M Kimball, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1989
Evolution of renal function in cardiac vs. renal allograft recipients receiving long-term cyclosporine A (CsA) immunosuppressive therapyR M Lewis, C T Van Buren, M Macris, et al.
Pageof 14

Showing results (101-110 of 135) with videos related to

Sort By:
Pageof 14
Transplantation Proceedings|April 1, 1986
Long-term results of cyclosporine therapy in recipients of mismatched living related kidneysS M Flechner, C T Van Buren, R H Kerman, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 1997
Ingested IFN-alpha has biological effects in humans with relapsing-remitting multiple sclerosisS A Brod, R H Kerman, L D Nelson, et al.
Transplantation|February 1, 1991
Chronic rejection in primary renal allograft recipients under cyclosporine-prednisone immunosuppressive therapyR J Knight, R H Kerman, M Welsh, et al.
Transplantation|January 1, 1988
The impact of cytomegalovirus infection on seronegative recipients of seropositive donor kidneys versus seropositive recipients treated with cyclosporine-prednisone immunosuppressionP C Johnson, R M Lewis, D L Golden, et al.
Transplantation|February 1, 1989
Stability of renal allograft function associated with long-term cyclosporine immunosuppressive therapy--five year follow-upR M Lewis, R P Janney, D L Golden, et al.
Transplantation Proceedings|April 26, 2005
Transplantation of single pediatric kidneys into adult recipientsZ Csapo, R J Knight, H Podder, et al.
Transplantation|February 1, 1991
Preemptive transplantation--an analysis of benefits and hazards in 85 casesS M Katz, R H Kerman, D Golden, et al.
Transplantation|February 1, 1991
AHG and DTE/AHG procedure identification of crossmatch-appropriate donor-recipient pairings that result in improved graft survivalR H Kerman, P M Kimball, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1991
Improved renal allograft survival for AHG and DTE/AHG crossmatch-negative recipientsR H Kerman, P M Kimball, C T Van Buren, et al.
Transplantation Proceedings|February 1, 1989
Evolution of renal function in cardiac vs. renal allograft recipients receiving long-term cyclosporine A (CsA) immunosuppressive therapyR M Lewis, C T Van Buren, M Macris, et al.
Pageof 14